The Point of Care Diagnostics/Testing Market Size was valued at USD 23.99 billion in 2022 and is expected to reach USD 58.97 billion by 2030, and grow at a CAGR of 11.9% over the forecast period 2023-2030.
The Point of Care Diagnostics/Testing Market is a rapidly growing sector in the healthcare industry. This market focuses on providing diagnostic tests and tools that can be performed at or near the patient's location, eliminating the need for samples to be sent to a laboratory for analysis.
One of the key drivers behind the growth of this market is the increasing demand for faster and more convenient diagnostic solutions. Point of care testing allows healthcare professionals to obtain immediate results, enabling them to make quicker decisions regarding patient care. This is particularly crucial in emergency situations or when time is of the essence.
Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2596
Another factor contributing to the expansion of this market is the rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and infectious diseases. Point of care diagnostics offer efficient monitoring and management options for these conditions, allowing patients to have better control over their health outcomes.
Moreover, technological advancements have played a significant role in enhancing point of care diagnostics. The development of portable devices with improved accuracy and reliability has made it easier for healthcare providers to diagnose and treat patients in a timely manner. These advancements have also led to the integration of point of care diagnostics with electronic health records, enabling seamless data sharing and analysis. Additionally, the increasing adoption of telemedicine has further expanded the reach of point of care diagnostics, allowing patients in remote areas to receive timely and accurate healthcare services. Overall, the combination of rising chronic diseases, technological advancements, and the integration of point of care diagnostics with other healthcare systems has revolutionized the way healthcare is delivered, leading to improved patient outcomes and better overall healthcare management.
KEY MARKET SEGMENTS
by End User
- Hospitals & Clinics
- Diagnostic Centers
- Homecare/Self Testing
- Others
by Mode of Purchase
- OTC Testing Products
- Prescription-based testing products
by Platform
- Immunoassays
- Molecular Diagnostics
- Dipsticks
- Others
by Product
- Glucose Monitoring
- Cardiometabolic Monitoring
- Infectious Disease Testing
- Coagulation Monitoring
- Pregnancy & Fertility Testing
- Hematology Testing
- Cancer/Tumor Marker Testing
- Urinalysis Testing
- Cholesterol
- Drugs-of-Abuse Testing
- Others
Major Players Listed in the Report are as Follows:
Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., PTS Diagnostics, Nova Biomedical, QuidelCorporation, Abbott Laboratories, Siemens Healthineers GmbH, Chembio Diagnostics, Inc., Becton, Dickinson and Company, Danaher Corporation and Other Players
Other Report
Real-Time PCR (qPCR) Market Growth
Bone Densitometer Market Growth
About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
info@snsinsider.com,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)